Organogenesis Inc. (ORGO)
NASDAQ: ORGO
· Real-Time Price · USD
5.21
-0.11 (-2.07%)
At close: May 06, 2025, 3:59 PM
5.20
-0.19%
Pre-market: May 07, 2025, 08:16 AM EDT
-2.07% (1D)
| Bid | 5.2 |
| Market Cap | 660.91M |
| Revenue (ttm) | 482.04M |
| Net Income (ttm) | 861K |
| EPS (ttm) | -0.01 |
| PE Ratio (ttm) | -521 |
| Forward PE | 27.42 |
| Analyst | Hold |
| Ask | 5.41 |
| Volume | 996,845 |
| Avg. Volume (20D) | 2,251,816 |
| Open | 5.27 |
| Previous Close | 5.32 |
| Day's Range | 5.15 - 5.42 |
| 52-Week Range | 2.21 - 6.71 |
| Beta | 1.85 |
About ORGO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORGO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ORGO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Organogenesis Inc. is scheduled to release its earnings on May 8, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+19.25%
Organogenesis shares are trading higher after Morg...
Unlock content with
Pro Subscription
2 months ago
+102.28%
Organogenesis shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY25 sales guidance above estimates.
2 months ago · seekingalpha.com
Organogenesis Holdings Inc. (ORGO) Q4 2024 Earnings Call TranscriptOrganogenesis Holdings Inc. (NASDAQ:ORGO ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Gary S. Gillheeney, Sr. – President and Chief Executive Officer Dave Franc...